Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Durate, Illinois Clinical Trials

A listing of Durate, Illinois clinical trials actively recruiting patient volunteers.

RESULTS

Found (18) clinical trials

A Study of OV101 in Individuals With Fragile X Syndrome

The purpose of this study is to assess the safety, tolerability and efficacy of oral OV101 (gaboxadol) in subjects with Fragile X syndrome.

Phase

4.34 miles

Learn More »

Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease

Hestia3 will evaluate the efficacy, safety and tolerability of ticagrelor versus placebo in children with SCD during treatment for at least 12 months and up to approximately 24 months. The target population are children aged 2 to <18 years of age and body weight of 12 kg diagnosed with HbSS ...

Phase

4.34 miles

Learn More »

Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

Our research is designed to determine mechanistically why consumption of a high red meat and saturated fat diet imparts risk for CRC development and to demonstrate that primary microbial risk factors (sulfidogenic and bile acid metabolizing bacteria) are modifiable by diet. The focus is on taurine, an overlooked sulfur amino ...

Phase N/A

4.34 miles

Learn More »

Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal

The goal of this study is to inform the sustainable implementation of cervical cancer screening services in low-resource areas of Senegal nave to cancer screening programs by investigating the access barriers and determinants of initial uptake and developing and adapting a peer education health promotion intervention to diverse and dynamic ...

Phase N/A

4.34 miles

Learn More »

Integrating Contextual Factors Into Clinical Decision Support

The term patient context refers to the myriad contextual factors in patients' lives that complicate the application of research evidence to patient care. For instance, the inability of a patient to afford a medication for a particular condition is a contextual factor. Contextual factors can be addressed when correctly identified. ...

Phase N/A

4.34 miles

Learn More »

Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA ) Technology

A multi-center study in which subjects that had completed or are completing a BNA test with the Auditory Oddball task (or other tests that will be commercially cleared at any given time), will have the option to complete additional investigational tasks and optional clinical assessments and questionnaire forms. At each ...

Phase N/A

4.34 miles

Learn More »

A Study to Evaluate the Efficacy Safety and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab in adult participants with moderate to severe hidradenitis suppurativa (HS).

Phase

5.52 miles

Learn More »

Subject Satisfaction With AbobutulinumtoxinA Treatment

An interventional Phase 4 study to assess subject satisfaction with abobotulinumtoxinA treatment.

Phase

6.11 miles

Learn More »

Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Stage I-III Limited Disease Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with Stage I-III LD-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Phase

6.19 miles

Learn More »

Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects 1 to Less Than 2 Years of Age With Cystic Fibrosis Homozygous for F508del

This study will evaluate the safety and pharmacokinetics (PK) of lumacaftor (LUM) and ivacaftor (IVA) in subjects 1 to less than 2 years of age with cystic fibrosis (CF), homozygous for F508del (F/F).

Phase

6.74 miles

Learn More »